Completed
Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect
NCT01072162
- Conditions
- Blood Coagulation Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States